文献速递支持与姑息治疗

COVID-19对医疗组织与肿瘤结局的影响

Impact of COVID-19 on healthcare organisation and cancer outcomes.
PubMed 文献 · Eur J Cancer · 2021-05-28

结果显示两种情景下6-8%患者延迟超过2个月,5年额外癌症死亡分别为88例和145例,对应2020年预期患者5年额外癌症死亡率为4.4%和6.8%。结论认为疫情相关诊疗延迟将影响患者生存,应告知患者不要推迟就医并保障肿瘤患者医疗资源。

要点

  • 两种回流情景下6-8%患者治疗延迟超过2个月。
  • 5年额外癌症死亡早期回流88例、晚期回流145例。
  • 2020年预期患者5年额外癌症死亡率分别为4.4%和6.8%。

核心结论

  • 疫情相关的诊断和治疗延迟预计会影响癌症患者生存。
  • 在疫情反复或需集中使用有限医院资源的事件中,应告知患者不要推迟就医,并保障肿瘤患者医疗资源。

研究设计与样本

  • 基于法国大型综合癌症中心出院数据库的患者级数据,采用离散事件模拟模型模拟疫情期间患者流动、诊疗路径和医院资源使用。
  • 使用基于文献的个体风险比估算5年预期额外癌症死亡数和死亡率。
  • 模拟期间需要医院照护的患者数为13,000例。

主要发现

  • 两种情景下估计有6-8%的患者延迟超过2个月。
  • 5年总体额外癌症死亡估计早期回流情景为88例,晚期回流情景为145例。
  • 肉瘤、妇科肿瘤、肝癌、头颈癌、乳腺癌和急性白血病估计额外死亡增加。
  • 2020年预期患者5年相对额外癌症死亡率两种情景分别为4.4%和6.8%。
  • 2021年预期患者分别为0.5%和1.3%,2022年预期患者均为0.5%。

临床怎么用

  • 应告知癌症患者不要因疫情推迟就医。
  • 在疫情反复或类似事件中应保障肿瘤患者的医疗资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Changes in the management of patients with cancer and delays in treatment delivery during the COVID-19 pandemic may impact the use of hospital resources and cancer mortality. PATIENTS AND METHODS: Patient flows, patient pathways and use of hospital resources during the pandemic were simulated using a discrete event simulation model and patient-level data from a large French comprehensive cancer centre's discharge database, considering two scenarios of delays: massive return of patients from November 2020 (early-return) or March 2021 (late-return). Expected additional cancer deaths at 5 years and mortality rate were estimated using individual hazard ratios based on literature. RESULTS: The number of patients requiring hospital care during the simulation period was 13,000. In both scenarios, 6-8% of patients were estimated to present a delay of >2 months. The overall additional cancer deaths at 5 years were estimated at 88 in early-return and 145 in late-return scenario, with increased additional deaths estimated for sarcomas, gynaecological, liver, head and neck, breast cancer and acute leukaemia. This represents a relative additional cancer mortality rate at 5 years of 4.4 and 6.8% for patients expected in year 2020, 0.5 and 1.3% in 2021 and 0.5 and 0.5% in 2022 for each scenario, respectively. CONCLUSIONS: Pandemic-related diagnostic and treatment delays in patients with cancer are expected to impact patient survival. In the perspective of recurrent pandemics or alternative events requiring an intensive use of limited hospital resources, patients should be informed not to postpone care, and medical resources for patients with cancer should be sanctuarised.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Bardet A, Fraslin AM, Marghadi J, et al. Impact of COVID-19 on healthcare organisation and cancer outcomes. Eur J Cancer. 2021. PMID: 34153714. doi:10.1016/j.ejca.2021.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。